Skip to main content
. 2023 Oct 12;10:694. doi: 10.1038/s41597-023-02611-3

Fig. 2.

Fig. 2

Bulk-cell analysis reveals the immune cell heterogeneity and prognosis between HPV+ and HPV− HNSCC. (a) Heatmap showing each cell type in HPV+ and HPV− tumors. (b) Ration comparison of each cell type in HPV+ and HPV− tumors. (c) Kaplan–Meier analysis of HPV+ and HPV− group dichotomized by the median level of plasma cells. (d). Kaplan–Meier analysis of the HPV+ and HPV− groups dichotomized by the median macrophage levels.